Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Pays Down Facility Borrowings Tied to Beckman Buy

NEW YORK (GenomeWeb News) – Danaher disclosed after the close of the market yesterday that it has reduced its commitments under a $3 billion unsecured revolving credit facility to zero and has terminated the facility, effective as of Dec. 29, 2011.

The Washington, DC-based conglomerate had inked the credit facility in June to help pay for its $6.8 billion acquisition of Beckman Coulter.

Danaher had reduced its commitments under the facility to $2.2 billion in late June, to $1.5 billion in July, and to $1 billion as of Oct. 1.

The firm said in a filing with the US Securities and Exchange Commission that there are now no outstanding borrowings under the facility and the termination does not trigger any termination penalties.

Last week, Danaher said that it expects its full-year 2012 EPS from continuing operations to be between $3.20 and $3.35 with core revenue growth from continuing operations of between 2 percent and 5 percent.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.